NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $293,020 | -19.7% | 491,975 | -22.5% | 0.00% | 0.0% |
| Q2 2023 | $365,058 | +15.9% | 634,663 | +41.6% | 0.00% | 0.0% |
| Q1 2023 | $315,059 | -13.6% | 448,227 | +177.8% | 0.00% | 0.0% |
| Q4 2022 | $364,599 | +972.4% | 161,327 | +1406.5% | 0.00% | – |
| Q3 2022 | $34,000 | -76.4% | 10,709 | -71.7% | 0.00% | -100.0% |
| Q2 2022 | $144,000 | -84.1% | 37,837 | -77.5% | 0.00% | -75.0% |
| Q1 2022 | $908,000 | +26.6% | 168,477 | +217.3% | 0.00% | 0.0% |
| Q4 2021 | $717,000 | +165.6% | 53,102 | +237.5% | 0.00% | +300.0% |
| Q2 2021 | $270,000 | -51.3% | 15,736 | -38.7% | 0.00% | -75.0% |
| Q4 2019 | $554,000 | +224.0% | 25,675 | +100.6% | 0.00% | +300.0% |
| Q1 2014 | $171,000 | – | 12,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |